We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Defining Training: How Does It Change Behavior?

Defining Training: How Does It Change Behavior?

January 21, 2015

When you ask them to define the word “training,” even seasoned trainers and instructional designers often are not able to provide a concise answer.  Training may best be defined as an organized attempt to change behavior. The science of psychology tells us that there are only three areas of behavior that training can change: cognitive, psychomotor and affective behavior.

Cognitive

Cognitive behavior is also known as the area of knowledge.  In this behavioral domain, we can add to or revise the body of knowledge an individual possesses.  A simple example is explaining a new gowning procedure required for certain areas of the facility. After training, employees know what is required of them.

Psychomotor

Psychomotor behavior is the demonstration of skills or physical manipulation of the body.  In this behavioral domain, we can add to or revise someone’s performance of a particular task or skill. For example, we can teach someone how to don a cap and gown properly by helping them do it. If that person can then perform the task successfully, we have affected his or her psychomotor behavior.

Affective

Affective behavior is the most intangible of the three. It can best be described as how we feel or think about a given subject.  Advertising, for example, aims directly at changing an audience’s affective behavior.  It does not try to provide any real knowledge about a product or teach any skill involved in using a product.  Advertising is all about making you feel or think that using a product will enhance your well-being; making you feel or think that using a particular product is good for you.

The same principle can be applied to training. For example, we can teach employees proper gowning procedures: the new knowledge effects a change in their cognitive behavior and the new skill in their psychomotor behavior. But have we changed their affective perception of the task? Do they understand why it is important to perform the task correctly?

To answer those questions, we can observe facility personnel to see if they are now meeting the gowning requirements.  If they are, we have reason to believe that the training successfully changed their affective behavior. They have understood and accepted the message that proper gowning is important.

Most training attempts to impact at least one of these behavior domains. Trainers need to know which one(s) they are aiming for and how to assess the result even before the training is conducted. Focus on the type of behavior change you want to see when planning your next training session.

Contact Information:
Dave Gallup
GMPTraining.com, Inc.
18585 Coastal Highway
Unit 10, #149
Rehoboth, DE 19971
215-870-5665
dagallup@gmptraining.com
www.gmptraining.com

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • GrayMatters Health’s Digital Therapy Device for PTSD Cleared

  • Dupixent Shows Positive Results in COPD Study

  • Advamedica’s Hemostat Cleared for Severe Surgical Bleeding

  • FDA Approves Sandoz’s Citrate-Free Adalimubab Formulation

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing